Inhibition of MDSCs through activation of STAT3, also drives changes in the phenotype and function of tumor-infiltrating MDSCs and reduces the production of inhibitory factors through the NF-kB and OXPHOS pathways. Here, NFKB1 is linked to neoplasm.